⌘K

Login Start Free

Home/Filings/4/0001649094-25-000051

4//SEC Filing

Lukatch Heath 4

Accession 0001649094-25-000051

CIK 0001649094other

View on SEC.gov Company Profile

Filed

Apr 9, 8:00 PM ET

Accepted

Apr 10, 8:06 AM ET

Size

10.4 KB

Accession

0001649094-25-000051

Insider Transaction Report

Form 4

Period: 2025-04-08

Vaxcyte, Inc.PCVX

Director

Transactions

Exercise/Conversion
Common Stock
2025-04-08$16.00/sh+6,000$96,000→ 13,175 total
Exercise/Conversion
Common Stock
2025-04-08$21.49/sh+1,000$21,490→ 14,175 total
Exercise/Conversion
Stock Option (right to buy)
2025-04-08−1,000→ 14,000 total
Exercise: $21.49Exp: 2031-06-01→ Common Stock (1,000 underlying)
Exercise/Conversion
Stock Option (right to buy)
2025-04-08−6,000→ 0 total
Exercise: $16.00Exp: 2030-06-10→ Common Stock (6,000 underlying)

Footnotes (1)

[F1]Fully vested and exercisable.

Documents

1 file

4
wk-form4_1744286786.xmlPrimary
FORM 4

Issuer

Vaxcyte, Inc.

CIK 0001649094

Entity typeother

Related Parties

1

filerCIK 0001596385

Filing Metadata

Form type: 4
Filed: Apr 9, 8:00 PM ET
Accepted: Apr 10, 8:06 AM ET
Size: 10.4 KB

View on SEC.gov